antibodies to T cells). Although less likely
in autologous transplantation, reactivation can occur
in T cell–depleted autologous recipients (e.g., patients being given antibodies to T cells for
the treatment of a T cell lymphoma with marrow depletion). EBV-LPD, whi[r]